“Committed to Excellence in Life Sciences Executive Search”
Akcea Therapeutics
Categories: Life Sciences, Pharmaceutical
Client: Akcea Therapeutics
Akcea Therapeutics has retained The Chase Group to secure a Chief Medical Officer to join the start-up organization. This person will be responsible for the overall strategic direction for development products and programs across all stages of development. These responsibilities will cover the full scope of clinical development functions including pre-clinical activities, Phase I (including human PK/PD) studies, as well as Phase II-IV trial design and execution. This position will work closely with the development teams ensuring effective strategy, design, execution and regulatory submission of development programs.
The Chase Group is pleased to announce the successful recruitment of Elvis Osei Tutu, PharmD, as the Vice President, Head of Regulatory Affairs at Checkmate…
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike…
The Chase Group’s track record for success continues with another executive placement secured for Arcturus Therapeutics. Entering a new stage in clinical development, Arcturus retained…
Biotechnology, Devices & Diagnostics, Life Sciences, Pharmaceutical
Biologics Consulting, currently experiencing a season of growth, retained The Chase to build out their leadership team. Tasked with identifying a Regulatory Project Management Lead,…
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience….